The Company is a Korea-based company mainly engaged in developing in vitro diagnostic (IVD) medical equipments and devices. The Company's product portfolio consists of ultrafast labchip systems, which utilize lab-on-a-chip with bio-diagnostic labchip technology, nano technology and system technology and are comprised of real-time polymerse chin rection (PCR) machines, plastic labchips, labchip cases, deoxyribonucleic acid (DNA)/ribonucleic acid (RNA) isolation machines, among others, and PCR reagents and kits. The Company's labchips are also used in various areas including clinical diagnostics, military diagnostics, food diagnostics, environmental diagnostics, animal diagnostics, and medical device and precision instrument manufacturing. The Company was founded on March 6,2009. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on Jun 22, 2015.
Headquarters
3,4Th Floor 54, Changeop-Ro, Sujeong-Gu, Seongnam-S, Gyeonggi-Do
Seoul; Seoul;
Contact Details: Purchase the Mico Biomed Co., Ltd. report to view the information.
Website: http://www.nanobiosys.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service